The Role of Sacubitril/Valsartan in HFrEF

(2:53)

Sacubitril / Valsartan (neprilysin inhibitor)

(1:54)

ARNI: sacubitril/valsartan. Mechanism of action, dosage, indications, side effects

(8:2)

A to Z of CV Pharmacotherapy | Valsartan Sacubitril: Has our PARADIGM shifted?

(53:46)

Adam DeVore, MD: Confidently Treating HF with Sacubitril/Valsartan

(1:59)

Sacubitril/Valsartan and Frailty in HFpEF in PARAGON-HF | ESC Congress 2022

(2:42)

Suggested dosing regimen of Sacubitril and Valsartan

(4:32)

Entresto (Sacubitril / Valsartan) Explained, the Good and the Bad: Side Effects and How I Use it.

(9:20)

ARNI (Sacubitril-Valsartan or Entresto) and SGLT2 Inhibitors for Heart Failure

(5:23)

Sacubitril/Valsartan : Should We Reshuffle the Deck in the Treatment of HF?

(26:17)

Sacubitril/valsartan vs Enalapril in acute heart failure - IHJ Report

(2:51)

What is Entresto?

(3:33)

New Agents for Heart Failure: Sacubitril/Valsartan

(16:46)

HFA 2020: Eligibility for sacubitril/valsartan in HF across the EF spectrum — Dr Gianluigi Savarese

(7:57)

Vymada 50 mg tablet | Entresto tablet | Sacubitril/valsartan | Sacubitril valsartan tablets

(10:35)

Entresto/ Vymada - Sacubitril Valsartan - How it Protect Heart? How it Works?

(9:1econd)

HFSA 2022: PROVE-HF: Effect of Sacubitril/Valsartan in HFrEF Pts With MR | Dr James L Januzzi

(7:42)

Sacubitril/Valsartan: Should We Reshuffle the Deck in the Treatment of HF?

(26:17)

Consistent Benefit of Sacubitril/Valsartan: More from PARADIGM-HF

(6:26)

MedTap: Why sacubitril/valsartan in heart failure with reduced ejection fraction?

(1:27)